#5041
|
|||
|
Soon
The top contender is a medication from Merck & Co. and Ridgeback Biotherapeutics called molnupiravir, Dieffenbach said. That is the product being tested in the Kellys’ Seattle trial. Two others are a candidate from Pfizer, known as PF-07321332, and AT-527, an antiviral produced by Roche and Atea Pharmaceuticals. They work by interfering with the virus’s ability to replicate in human cells. In the case of molnupiravir, the enzyme that copies the viral genetic material is forced to make so many mistakes that the virus can’t reproduce. That, in turn, reduces a patient’s viral load, shortening infection time and preventing the kind of dangerous immune response that can cause serious illness or death. I personally can’t wait when the Merck one is released. I have a lot of idiots taking ivermectin in my office and say they will now only trust drugs that come from Merck (makers of Ivermectin) from now on due to the life saving deworming paste they are taking. Meanwhile all they are having is massive intestinal issues and more. | ||
|
#5042
|
|||
|
| ||
|
#5043
|
||||
|
Quote:
| |||
|
#5047
|
|||
|
Debt limit "obstruction" to force using reconciliation on not defaulting?
It's more likely than you think. 🐶 | ||
|
#5049
|
|||
|
politics as sports
| ||
|
#5050
|
|||
|
Universal Pre-K is a great idea and I hope that part passes.
Cutting $3600 checks each year is an incredibly bad use of money. Locking dentists into medicare rates is hilarious. I don't know how taxes work but I hope I don't have to pay more but I get the feeling I will. | ||
|
|
|